New York cannabis regulators on Tuesday sought to make up for delays in the drug’s rollout by approving a chief equity officer and making immediate changes to the medical cannabis program during the inaugural meeting of the state Cannabis Control Board.
The five-member board charged with implementing cannabis legalization and advancing the state's cannabis industry set a clear tone: they wanted to move past delays in implementing the Marijuana Regulation and Taxation Act.
The state law legalizing cannabis took effect in March, but infighting between then-Gov. Andrew Cuomo and the state Legislature exacerbated delays in getting members appointed to the board, slowing down the work of getting regulations for legal sales in place.
“The MRTA was signed into law on March 31. But we were not able to begin the work of establishing New York’s cannabis market until September 2022, when the full cannabis control board was appointed. As such, there was a six-month delay to make up,” Christopher Alexander, executive director of the Office of Cannabis Management, told the board Tuesday afternoon.
Read more at https://eu.lohud.com